Vanguard Health Care ETF (VHT)

Add to Watchlists Create an Alert
117.18 +0.55  +0.47% NYSE Arca Aug 29, 5:00PM BATS Real time Currency in USD
View Full Chart
VHT Price Chart

VHT Description

Vanguard Health Care ETF is a long only equity fund managed by Vanguard that tracks the MSCI US IMI/Health Care 25-50 GR USD index and has 3.286B USD assets under management. It has an expected distribution yield of 1.39%, a Prospective PE Ratio of 20.68, and a Prospective Price to Book Value of 3.349. The fund has a net expense ratio of 0.14%, turns over its positions 5.00% per year, and is traded on the New York Stock Exchange Arca.

Benchmark Index: MSCI US IMI/Health Care 25-50 GR USD

VHT Key Info

Expense Ratio (12-23-13) 0.14%
Assets Under Management (8-27-14) 3.286B
30-Day Average Volume (8-28-14) 166297.8
Net Asset Value (8-27-14) 116.84
Discount or Premium to NAV (8-27-14) 0.02%
Turnover Ratio (8-31-13) 5.00%

VHT Asset Allocation

Type % Net % Long % Short
Cash 0.00% 0.00% 0.00%
Stock 100.00% 100.00% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of July 31, 2014

VHT Region Exposure

Americas 96.94%
North America 96.92%
Latin America 0.01%
Greater Europe 3.01%
United Kingdom 0.00%
Europe Developed 3.01%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.05%
Japan 0.00%
Australasia 0.05%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.00%
% Emerging Markets 0.00%
As of July 31, 2014
Region breakdown data is calculated by using the long position holdings of the portfolio.

VHT Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.03%
Energy 0.00%
Financial Services 0.08%
Healthcare 98.38%
Industrials 0.27%
Real Estate 0.00%
Technology 1.25%
Utilities 0.00%
As of July 31, 2014

VHT Stock Market Capitalization

Giant 47.59%
Large 33.33%
Medium 11.95%
Small 4.58%
Micro 2.55%
As of July 31, 2014
View More Holdings

VHT Top 10 Holdings

Name % Weight Price Chg %
Johnson & Johnson 10.14% 103.73 +0.76%
Pfizer Inc 6.56% 29.40 +0.07%
Merck & Co Inc 5.98% 60.11 +0.18%
Gilead Sciences Inc 5.04% 107.61 +0.09%
Amgen Inc 3.45% 139.23 +0.39%
Bristol-Myers Squibb Company 2.99% 50.65 +0.22%
AbbVie Inc 2.98% 55.28 -0.58%
UnitedHealth Group Inc 2.87% 86.68 +0.39%
Biogen Idec Inc 2.83% 343.04 +0.53%
Celgene Corp 2.54% 94.97 +0.29%
As of July 31, 2014
Get Quote for
Advertisement

VHT Risk Info

Beta 0.7541
Max Drawdown (1-26-04 to 8-28-14) 40.83%
30 Day Average Volatility 12.16%

VHT Fundamentals

Distribution Yield TTM (8-29-14) 1.39%
Distribution Yield (Prospective) 1.40%
PE Ratio (Prospective) 20.68
PS Ratio (Prospective) 1.766
Price to Book Value (Prospective) 3.349
ROE 17.49%
ROA 6.99%
Number of Holdings 308.00
As of July 31, 2014

VHT Growth Estimates

Forecasted 5 Yr Earnings Growth 10.37%
Forecasted Book Value Growth 8.69%
Forecasted Cash Flow Growth 1.60%
Forecasted Earnings Growth -12.49%
Forecasted Revenue Growth 7.54%
As of July 31, 2014

VHT Performance

  Returns Total Returns
1M 3.85% 3.85%
3M 8.84% 8.84%
6M 7.40% 7.40%
1Y 30.24% 31.73%
3Y 104.2% 113.6%
5Y 132.1% 153.7%
As of Aug. 27, 2014

VHT Flows

1M 56.25M
3M 435000.0
6M 301.31M
YTD 427.36M
1Y 701.26M
3Y 1.385B
5Y 1.485B
As of July 31, 2014
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.